Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Titled Monoclonal Therapeutics and Diagnostic Imaging Products: The Global Market (Bio016g), the report showed the global market for monoclonal therapeutic and diagnostic antibodies was worth $31 billion in 2007. This is expected to increase to over $56 billion by 2012, a compound average annual growth rate (CAGR) of 13%.
For more information on the report, visit www.bccresearch.com.
Super-strong antibodies developed for cancer treatment
Scientists discovered that their antibody prototype, which was more rigid, was able to trigger a...
Testing more antibodies with fewer lab mice
Researchers have developed a technology that can be used to test 25 antibodies simultaneously in...
Nanofibre uniform protects soldiers against chemical threats
A next-generation uniform prototype employs nanofibres to safeguard wearers from chemical and...
